Fas ligand promotes cell survival of immature human bone marrow CD34+CD38− hematopoietic progenitor cells by suppressing apoptosis
Authors:
- Dag JosefsenDJDag Josefsen
- June H. MyklebustJMJune H. Myklebust
- Trond StokkeTSTrond Stokke
- Erlend B. SmelandESErlend B. Smeland
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (9) , 1451-1459
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of CD95/Fas and its ligand in the regulation of the growth of human CD34++CD38− fetal liver cellsExperimental Hematology, 1999
- MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1Nature, 1997
- Apoptosis by Death FactorCell, 1997
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Fas transduces activation signals in normal human T lymphocytes.Journal of Experimental Medicine, 1993
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryJournal of Immunological Methods, 1991
- Monoclonal Antibody-Mediated Tumor Regression by Induction of ApoptosisScience, 1989
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.Journal of Experimental Medicine, 1989